Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study.

Sood P, Senanayake S, Sujeet K, Medipalli R, Zhu YR, Johnson CP, Hariharan S.

Transplantation. 2012 Oct 27;94(8):814-21. doi: 10.1097/TP.0b013e31826690c6.

PMID:
23018881
2.

Monitoring of polyomavirus BK replication and impact of preemptive immunosuppression reduction in renal-transplant recipients in China: a 5-year single-center analysis.

Huang G, Wang CX, Zhang L, Fei JG, Deng SX, Qiu J, Li J, Chen GD, Fu Q, Chen LZ.

Diagn Microbiol Infect Dis. 2015 Jan;81(1):21-6. doi: 10.1016/j.diagmicrobio.2014.09.024. Epub 2014 Oct 2.

PMID:
25445121
3.

Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy.

Saad ER, Bresnahan BA, Cohen EP, Lu N, Orentas RJ, Vasudev B, Hariharan S.

Transplantation. 2008 Mar 27;85(6):850-4. doi: 10.1097/TP.0b013e318166cba8.

PMID:
18360267
4.

Everolimus leads to a lower risk of BKV viremia than mycophenolic acid in de novo renal transplantation patients: a single-center experience.

Moscarelli L, Caroti L, Antognoli G, Zanazzi M, Di Maria L, Carta P, Minetti E.

Clin Transplant. 2013 Jul-Aug;27(4):546-54. doi: 10.1111/ctr.12151. Epub 2013 Jun 13.

PMID:
23758330
5.

The impact of surveillance and rapid reduction in immunosuppression to control BK virus-related graft injury in kidney transplantation.

Elfadawy N, Flechner SM, Liu X, Schold J, Tian D, Srinivas TR, Poggio E, Fatica R, Avery R, Mossad SB.

Transpl Int. 2013 Aug;26(8):822-32. doi: 10.1111/tri.12134. Epub 2013 Jun 14.

6.

Prospective monitoring of BK virus replication in renal transplant recipients.

Koukoulaki M, Grispou E, Pistolas D, Balaska K, Apostolou T, Anagnostopoulou M, Tseleni-Kotsovili A, Hadjiconstantinou V, Paniara O, Saroglou G, Legakis N, Drakopoulos S.

Transpl Infect Dis. 2009 Feb;11(1):1-10. doi: 10.1111/j.1399-3062.2008.00342.x. Epub 2008 Sep 21.

PMID:
18811631
7.

The status of BK polyomavirus replication in adult renal transplant recipients in northeastern Poland.

Naumnik B, Kowalewska J, Zalewski G, Charkiewicz R, Myśliwiec M.

Transplant Proc. 2011 Oct;43(8):2976-84. doi: 10.1016/j.transproceed.2011.07.009.

PMID:
21996205
8.

BK viremia surveillance after kidney transplant: single-center experience during a change from cyclosporine-to lower-dose tacrolimus-based primary immunosuppression regimen.

Geddes CC, Gunson R, Mazonakis E, Wan R, Thomson L, Clancy M, Carman WF.

Transpl Infect Dis. 2011 Apr;13(2):109-16. doi: 10.1111/j.1399-3062.2010.00566.x. Epub 2010 Sep 7.

PMID:
21457419
9.
10.

Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients.

Vu D, Shah T, Ansari J, Naraghi R, Min D.

Transplant Proc. 2015 Mar;47(2):394-8. doi: 10.1016/j.transproceed.2015.01.012.

PMID:
25769580
11.

Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.

Knight RJ, Gaber LW, Patel SJ, DeVos JM, Moore LW, Gaber AO.

Transplantation. 2013 Apr 15;95(7):949-54. doi: 10.1097/TP.0b013e31828423cd.

PMID:
23545506
12.

Observations on the use of cidofovir for BK virus infection in renal transplantation.

Kuten SA, Patel SJ, Knight RJ, Gaber LW, DeVos JM, Gaber AO.

Transpl Infect Dis. 2014 Dec;16(6):975-83. doi: 10.1111/tid.12313. Epub 2014 Nov 21.

PMID:
25412701
13.

Risk factors for BK virus infection in the era of therapeutic drug monitoring.

Borni-Duval C, Caillard S, Olagne J, Perrin P, Braun-Parvez L, Heibel F, Moulin B.

Transplantation. 2013 Jun 27;95(12):1498-505. doi: 10.1097/TP.0b013e3182921995.

PMID:
23778568
14.

BK virus nephritis after renal transplantation.

Hariharan S.

Kidney Int. 2006 Feb;69(4):655-62. Review.

15.

Prospective monitoring of BK virus reactivation in renal transplant recipients in North India.

Thakur R, Arora S, Nada R, Minz M, Joshi K.

Transpl Infect Dis. 2011 Dec;13(6):575-83. doi: 10.1111/j.1399-3062.2011.00634.x. Epub 2011 Apr 20.

PMID:
21507160
16.

Association of BK Virus Titers With Lymphocyte Count in Renal Transplant Patients.

Velioglu A, Aksu B, Asicioglu E, Arıkan H, Tinay I, Yardimci S, Yegen C, Tuglular S, Ozener C.

Transplant Proc. 2015 Jun;47(5):1421-4. doi: 10.1016/j.transproceed.2015.04.042.

PMID:
26093733
17.

The risk of polyomavirus-associated graft nephropathy is increased by a combined suppression of CD8 and CD4 cell-dependent immune effects.

Renner FC, Dietrich H, Bulut N, Celik D, Freitag E, Gaertner N, Karoui S, Mark J, Raatz C, Weimer R, Feustel A.

Transplant Proc. 2013 May;45(4):1608-10. doi: 10.1016/j.transproceed.2013.01.026.

PMID:
23726630
18.

Currently recommended BK virus (BKV) plasma viral load cutoff of ≥4 log10/mL underestimates the diagnosis of BKV-associated nephropathy: a single transplant center experience.

Hassan S, Mittal C, Amer S, Khalid F, Patel A, Delbusto R, Samuel L, Alangaden G, Ramesh M.

Transpl Infect Dis. 2014 Feb;16(1):55-60. doi: 10.1111/tid.12164. Epub 2013 Nov 12.

PMID:
24283677
19.

High-dose steroid therapy in BK viremia adversely affected the long-term graft function after kidney transplantation.

Kim H, Yu H, Baek CH, Han DJ, Park SK.

Transpl Infect Dis. 2016 Dec;18(6):844-849. doi: 10.1111/tid.12604. Epub 2016 Oct 20.

PMID:
27622599
20.

Polyomavirus infection in pediatric renal transplant recipients: evaluation using a quantitative real-time PCR technique.

Herman J, Van Ranst M, Snoeck R, Beuselinck K, Lerut E, Van Damme-Lombaerts R.

Pediatr Transplant. 2004 Oct;8(5):485-92.

PMID:
15367285

Supplemental Content

Support Center